Dr. Lim is a Consultant Neurologist and Professor at the University of Malaya, Kuala Lumpur, where he runs a very busy government clinic and private practice seeing many patients (around 70 every week) with Parkinson’s disease (PD) and other Movement Disorders, including complicated cases requiring advanced treatments such as deep brain stimulation. Dr. Lim earned his medical and research doctorate degrees from the University of Melbourne and was admitted to Fellowship of the Royal Australasian College of Physicians after completing advanced training in adult Internal Medicine and Neurology in Melbourne. Dr. Lim trained in general neurology and subspecialized in Parkinson’s & Movement Disorders, at world-renowned centres in Melbourne and Toronto (the latter supported by the Edmond J. Safra Fellowship, under Prof. Anthony Lang). He has published widely in the field of Movement Disorders (Parkinson's as well as a variety of rarer movement disorders), with approx. 150 peer-reviewed journal papers and book chapters, including first-author publications in Lancet Neurology, Archives of Neurology/JAMA Neurology, Movement Disorders, etc. and co-authorship in journals such as Nature Genetics, Nature Reviews Neurology, Annals of Neurology, and Brain (approx. 10K citations, h-index 44). He is on several Editorial Boards including Parkinsonism & Related Disorders and Neurotorium, and is an Associate Editor for Nature Partner Journal (npj) Parkinson's Disease and Neurology Asia (for several years previously also for Science Advances), and Guest Editor for the Journal of Parkinson's Disease. Dr. Lim is the current Chair of the Asian-Oceanian section of the International Parkinson & Movement Disorder Society (MDS) (which has approx. 3.5K members, from the Clinical and Basic science communities), and serves on several MDS Committees/Task Forces (for Evidence-Based Medicine; Progressive Supranuclear Palsy; Movement Disorders in Asia; Palliative Care; etc.). He is a Steering Committee member, and Co-Lead of the Under-Represented Populations Working Group, of the Global Parkinson's Genetics Program (GP2). He is a holder and/or Reviewer of grants for PD-related funding organisations such as the Michael J. Fox Foundation (MJFF), and the United Kingdom's National Institute for Health and Care Research (NIHR) and Cure Parkinspn's Trust (CPT). With a strong commitment to teaching/training, Dr. Lim has organized numerous teaching courses on Parkinson’s & Movement Disorders, and delivered and/or participated in hundreds of international-level lectures and expert panels throughout Asia-Oceania, North America, and Europe. These have often been under the auspices of the MDS, as MDS Visiting Professor, MDS Ambassador, or MDS Virtual Professor. As a versatile speaker with broad-ranging expertise, he has been invited to give numerous Plenary Lectures, including at the flagship MDS Annual Congress (Toronto 2011, Dublin 2012, Nice 2019, Philadelphia/Virtual 2020, Copenhagen 2023, Honolulu 2025) and at the World Parkinson's Congress (Kyoto 2019). In 2025, together with Profs. Nobutaka Hattori and Pramod Pal, he Chaired a highly successful 9th Asian & Oceanian Parkinson's & Movement Disorders Congress (AOPMC) in Tokyo. He has provided movement disorder fellowship/observership training to neurologists from multiple underserved countries, including Indonesia, Myanmar, Bangladesh, Kyrgyzstan, Uzbekistan, Pakistan, India, the Philippines, and Nigeria, often under the auspices of the MDS (Visiting Trainee Grants or Centre-to-Centre Programs). Dr. Lim is a Medical Advisor to the Malaysian Parkinson’s Disease Association, and a founding member (and Immediate-Past Chair) of the Malaysian Movement Disorder Council. He was elected as a Fellow of the Malaysian Academy of Sciences in 2017. In recognition of his leadership in the Movement Disorders field, he was invited to be an Expert Panelist/Consultant to the World Health Organization (WHO) in 2020 to address global policy, implementation and research related to PD. Dr. Lim's research interests are multi-dimensional, with a focus on the following areas: (i) PD (particularly genetics and genotype-phenotype correlations; evidence-based medicine/clinical trials; non-motor features including gastrointestinal aspects; comorbidities; patient-centred care; and rating scales/disease staging); (ii) Parkinson-plus syndromes and other miscellaneous/"orphan" movement disorders, including progressive supranuclear palsy (PSP).

I, Chia Jee Luen, was born in Pantai Remis, Perak, Malaysia, in 1984. I completed my undergraduate and postgraduate studies in the Department of Chinese Studies at Universiti Malaya and subsequently obtained a Ph.D. in Ancient Literature from Shandong University, China, in 2019. I previously served as a researcher for the "Research, Translation, and Publication of Dream of the Red Chamber in Malaysia (Mimpi Di Mahligai Merah)" project.I am currently a senior lecturer and researcher at the Hong Lou Meng Research Center in the Department of Chinese Studies at Universiti Malaya. I hold the position of secretary of the Persatuan Siswazah Jabatan Pengajian Tionghoa (PEJATI) and am a member of the Writers' Association of Chinese Medium of Malaysia. My teaching and research fields include classical Chinese novels such as "Dream of the Red Chamber" and literary dissemination studies.I have authored the book "The Dissemination and Research of 'Dream of the Red Mansions' in Malaysia and Singapore (1818-2018)" and co-edited two monographs: "Transplanting Flowers and Cultivating Dreams: Dr. Seng Yan Chuan's Works on Redology" (2023) and "Chan Kong Choy Hong Lou Meng Research Books Collection Catalog and Review" (2015). I have published over twenty articles in various journals, namely "Hong Lou Meng Xuekan (Studies on 'Dream of the Red Mansions')", "Cao Xueqin Yanjiu (The Study of Cao Xueqin)", "Hong Lou Meng Yanjiu (Studies on 'Dream of the Red Mansions')", "Asian Culture", "Forum for World Literature Studies", and "Journal of Chinese Literature and Culture", as well as in local and international publications.谢依伦（Chia Jee Luen），1984年出生于马来西亚霹雳州班台，祖籍广东潮州澄海。硕士毕业于马来亚大学（简称“马大”）中文系，2019 年获得山东大学古代文学博士学位。曾任“马来文版《红楼梦》（Mimpi Di Mahligai Merah）研究、翻译及出版计划”研究员、马大《红楼梦》研究中心博士后研究员。现为马大中文系高级讲师、马大《红楼梦》研究中心研究员兼秘书、马大中文系毕业生协会秘书长、马来西亚华文作家会员兼查账。2024年荣获马来亚大学颁发的卓越服务奖状（SPC Sijil Perkhidmatan Cemerlang）。教学及研究方向为中国古代小说、《红楼梦》研究以及文学传播学。著有《〈红楼梦〉在马来西亚和新加坡的传播与研究》，合编著《移花植梦：孙彦莊的红学文集》、《陈广才红学研究藏书目录及评介》。在《红楼梦学刊》《曹雪芹研究》《世界文学研究论坛》《アジア文化 Asian Culture》《马大华人文化与文学》等期刊及国内外书刊发表论文二十余篇。

Associate Professor Dr Loh Pui San is a Senior Consultant Anaesthesiologist and the Head of Department for Anaesthesiology and Critical Care Department, Faculty of Medicine. She specializes in the clinical field of transplant anaesthesia and perioperative medicine, in particular geriatric anaesthesia. Dr Loh believes that as the Malaysian population ages and increasingly more elderly individuals require surgery at the end of their lifetimes, this is a field that deserves expert attention with equal focus similar to the other extreme of age for children.   An undergraduate Alumni from University Malaya and postgraduate from Universiti Kebangsaan Malaysia, she has worked in many tertiary hospitals such as HKL, HUKM, IJN and Selayang before focusing on her academic career in University Malaya. She hopes to build the field of geriatric anaesthesia among her colleagues working in public (both Ministry of Health and Education) or private institutions via her active involvement in the Malaysian Society of Anaesthesiologists. Dr Loh is also currently working on preparing a national Clinical Practice Guideline for Hip Fractures in the Elderly as part of an expert panel with the Ministry of Health.   Her research interest includes studying perioperative management for major abdominal surgery, transplant, and effects of anesthesia on the elderly for which she has obtained ongoing national and international grants for. In her research involving the geriatric population, Dr Loh has keen interest to study what is best for them when they present for surgery especially in finding suitable assessment to identify risk factors early, institute prevention and provide safe methods of anaesthesia.